ASP Isotopes Inc. is an advanced materials company focused on developing isotope enrichment technologies for specialized markets. The company works on producing and commercializing isotopes used in nuclear medicine, semiconductors, advanced nuclear fuels, and other industrial applications. Its current business is organized around Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment is centered on technologies for high-assay low-enriched uranium and lithium-6, while the Specialist Isotopes segment targets high-value, low-volume isotopes such as carbon-14, molybdenum-100, and silicon-28. ASP Isotopes Inc. also develops related enrichment and separation processes designed to support critical materials supply chains across healthcare, energy, and technology industries. Founded in 2021 and headquartered in Dallas, Texas, ASP Isotopes Inc. is positioned as a supplier of specialized isotope products and services in niche global markets.
Omsætning og resultat (USD)
Gns. kursmål: $13,00
ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock
GlobeNewswire Inc. · 15. jul. 2026
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
GlobeNewswire Inc. · 20. mar. 2026
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf
GlobeNewswire Inc. · 18. mar. 2026
ASP Isotopes Inc. is an advanced materials company focused on developing isotope enrichment technologies for specialized markets. The company works on producing and commercializing isotopes used in nuclear medicine, semiconductors, advanced nuclear fuels, and other industrial applications. Its current business is organized around Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment is centered on technologies for high-assay low-enriched uranium and lithium-6, while the Specialist Isotopes segment targets high-value, low-volume isotopes such as carbon-14, molybdenum-100, and silicon-28. ASP Isotopes Inc. also develops related enrichment and separation processes designed to support critical materials supply chains across healthcare, energy, and technology industries. Founded in 2021 and headquartered in Dallas, Texas, ASP Isotopes Inc. is positioned as a supplier of specialized isotope products and services in niche global markets.
Omsætning og resultat (USD)
Gns. kursmål: $13,00
ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock
GlobeNewswire Inc. · 15. jul. 2026
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf
GlobeNewswire Inc. · 20. mar. 2026
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf
GlobeNewswire Inc. · 18. mar. 2026